Market Tracker

12/11 3:59pm ET

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

16.45
Delayed Data
As of 3:59pm ET
 +0.385 / +2.40%
Today’s Change
10.85
Today|||52-Week Range
38.31
-54.63%
Year-to-Date
Teva Stock Rises After Announcing Launch of Generic Viagra Competitor
1:30pm / TheStreet.com - Paid Partner Content
Staying Liquid
Dec 07 / TheStreet.com - Paid Partner Content
Bear of the Day: Mallinckrodt PLC (MNK)
Dec 08 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer/Merck KGaA Drug Fails in Study, Teva CEO Announces Chang...
Dec 01 / Zacks.com - Paid Partner Content
David Abrams Buys Teva Pharmaceutical Industries, O'Reilly Automotive Inc, Asbury Aut...
Dec 07 / GuruFocus News - Paid Partner Content
Teva's New CEO Re-Shuffles Senior Management, Stock Up 7%
Nov 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close16.06
Today’s open16.02
Day’s range16.02 - 16.74
Volume1,298,861
Average volume (3 months)27,254,116
Market cap$16.3B
Dividend yield5.17%
Data as of 3:59pm ET, 12/11/2017

Growth & Valuation

Earnings growth (last year)-96.18%
Earnings growth (this year)-25.63%
Earnings growth (next 5 years)-5.19%
Revenue growth (last year)+12.01%
P/E ratioNM
Price/Sales1.59
Price/Book0.55

Competitors

 Today’s
change
Today’s
% change
BGNEBeiGene Ltd-4.53-4.72%
TYMETyme Technologies In...-0.26-6.77%
OASMOasmia Pharmaceutica...-0.03-3.00%
Data as of 3:58pm ET, 12/11/2017

Financials

Next reporting dateFebruary 8, 2018
EPS forecast (this quarter)$0.75
Annual revenue (last year)$22.0B
Annual profit (last year)$330.0M
Net profit margin1.50%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Kåre Schultz
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts